RANKL/TNFSF11, Human

Availability: 24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Dry Ice Shipment: No

Alternative Products

Cat	Name
Z102265	Recombinant Human RANKL (TNFSF11)
Z102269	Recombinant Human RANKL (TNFSF11)
MBS4159836-02	Recombinant Human RANKL (TNFSF11)
MBS4159836-01	Recombinant Human RANKL (TNFSF11)
MBS495579-01	TNFSF11/RANKL ELISA
MBS495579-02	TNFSF11/RANKL ELISA
PKSH031027-01	Recombinant Human RANKL/TNFSF11 Protein
LF-EK50929	Human TNFSF11/RANKL ELISA Kit
MBS177352-02	Human TNFSF11/RANKL ELISA Kit
MBS177352-01	Human TNFSF11/RANKL ELISA Kit

CAT:

804-HY-P7424-02

Size:

2 µg

Price:

Ask

For price, please contact [email protected].

RANKL/TNFSF11, Human

UNSPSC Description: RANKL (TNFSF11), a type II transmembrane protein, is receptor activator of NF-κB (RANK) ligand. RANKL is an activator of RANK. When binding to RANK, it induces the differentiation of monocyte/macrophage-lineage cells into osteoclasts and leads to osteoclast precursor maturation. RANKL is critical for osteoclasts maturation, bone modeling, and bone remodeling, as well as the development of lymph nodes (LNs). RANKL/TNFSF11 Protein, Human is a recombinant human RANKL (I140-D317) without any tag, which is produced in E.coli[1][2].
Type: Recombinant Proteins
Assay Protocol: https://www.medchemexpress.com/cytokines/rank-l-tnfsf11-protein-human.html
Purity: 98.0
Smiles: IRAEKAMVDG SWLDLAKRSK LEAQPFAHLT INATDIPSGS HKVSLSSWYH DRGWAKISNM TFSNGKLIVN QDGFYYLYAN ICFRHHETSG DLATEYLQLM VYVTKTSIKI PSSHTLMKGG STKYWSGNSE FHFYSINVGG FFKLRSGEEI SIEVSNPSLL DPDQDATYFG AFKVRDID
Molecular Weight: Approximately 20 kDa
References & Citations: [1]Hofbauer LC, et al. Role of receptor activator of nuclear factor-kappaB ligand and osteoprotegerin in bone cell biology. J Mol Med (Berl). 2001 Jun;79(5-6):243-53.|[2]Ono T, et al. RANKL biology: bone metabolism, the immune system, and beyond. Inflamm Regen. 2020 Feb 7;40:2.|[3]Li B, et al. Roles of the RANKL-RANK Axis in Immunity-Implications for Pathogenesis and Treatment of Bone Metastasis. Front Immunol. 2022 Mar 21;13:824117.|[4]Tobeiha M, et al. RANKL/RANK/OPG Pathway: A Mechanism Involved in Exercise-Induced Bone Remodeling. Biomed Res Int. 2020 Feb 19;2020:6910312.|[5]Mikami S, et al. Increased RANKL expression is related to tumour migration and metastasis of renal cell carcinomas. J Pathol. 2009 Aug;218(4):530-9.|[6]Peng X, et al. Differential expression of the RANKL/RANK/OPG system is associated with bone metastasis in human non-small cell lung cancer. PLoS One. 2013;8(3):e58361.|[7]Lloyd SA, et al. Soluble RANKL induces high bone turnover and decreases bone volume, density, and strength in mice. Calcif Tissue Int. 2008 May;82(5):361-72.
Shipping Conditions: Blue Ice
Storage Conditions: Stored at -20°C for 2 years

Complementary Product Range

Our range of products, including RANKL/TNFSF11, Human, falls within the same field of application and can be used across various research projects. These products are carefully selected for their high performance and reliability, supporting the diverse needs of modern laboratories. Whether for ongoing studies or future experiments, they are designed to help researchers achieve their scientific goals. Here are some related products that may be of interest for similar or future applications:

Each item in our collection, is tested for precision and quality, ensuring dependable solutions for your research. As we continue to incorporate the latest advancements, Gentaur ensures that our product range remains relevant and versatile, providing you with the tools needed for both current and future projects.

Find us on

Cat	Name
HY-P7424-02	RANKL/TNFSF11, Human
HY-P7424-03	RANKL/TNFSF11, Human
HY-P7424-01	RANKL/TNFSF11, Human
HY-P73386-05	RANKL/TNFSF11, Human (HEK293)
HY-P73386-04	RANKL/TNFSF11, Human (HEK293)
HY-P73386-02	RANKL/TNFSF11, Human (HEK293)
HY-P73386-03	RANKL/TNFSF11, Human (HEK293)
HY-P73386-01	RANKL/TNFSF11, Human (HEK293)
HY-P73387-02	RANKL/TNFSF11, Human (HEK293, hFc)
HY-P73387-03	RANKL/TNFSF11, Human (HEK293, hFc)